Mucins, Mucus, and Goblet Cells

Chest

Volumn 154, Issue 1, 2018, Pages 169-176

  Ma, Jonathan ^a   Rubin, Bruce K ^a   Voynow, Judith A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

asthma; COPD; cystic fibrosis; goblet cell; mucin

Indexed keywords

AZITHROMYCIN; IVACAFTOR; MUCIN; MUCIN 1; MUCIN 2; MUCIN 4; MUCIN 5AC; MUCIN 5B; MUCIN 6; MUCIN 7; MUCIN 8;

ASTHMA; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CILIARY DYSKINESIA; CYSTIC FIBROSIS; EMCN GENE; GENE; GOBLET CELL; HUMAN; INNATE IMMUNITY; LUNG FIBROSIS; MUC1 GENE; MUC12 GENE; MUC13 GENE; MUC15 GENE; MUC16 GENE; MUC17 GENE; MUC19 GENE; MUC2 GENE; MUC20 GENE; MUC21 GENE; MUC22 GENE; MUC3A GENE; MUC3B GENE; MUC4 GENE; MUC5AC GENE; MUC5B GENE; MUC6 GENE; MUC7 GENE; MUC8 GENE; NONHUMAN; OVGP1 GENE; PRIORITY JOURNAL; RESPIRATORY MUCOSA; REVIEW; AIRWAY REMODELING; ANIMAL; METABOLISM; MUCOCILIARY CLEARANCE; MUCUS; PATHOLOGY; PATHOPHYSIOLOGY;

AIRWAY REMODELING; ANIMALS; CYSTIC FIBROSIS; GOBLET CELLS; HUMANS; MUCINS; MUCOCILIARY CLEARANCE; MUCUS;

EID: 85044525925     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1016/j.chest.2017.11.008     Document Type: Review

References (92)

1. Voynow, J.A., Rubin, B.K., Mucins, mucus, and sputum. Chest 135:2 (2009), 505–512.
2. Button, B., Cai, L.H., Ehre, C., et al. A periciliary brush promotes the lung health by separating the mucus layer from airway epithelia. Science 337:6097 (2012), 937–941.
3. Hoegger, M.J., Fischer, A.J., McMenimen, J.D., et al. Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis. Science 345:6198 (2014), 818–822.
4. Bonser, L.R., Zlock, L., Finkbeiner, W., Erle, D.J., Epithelial tethering of MUC5AC-rich mucus impairs mucociliary transport in asthma. J Clin Invest 126:6 (2016), 2367–2371.
5. Hill, D.B., Vasquez, P.A., Mellnik, J., et al. A biophysical basis for mucus solids concentration as a candidate biomarker for airways disease. PLoS One, 9(2), 2014, e87681.
6. Innes, A.L., Woodruff, P.G., Ferrando, R.E., et al. Epithelial mucin stores are increased in the large airways of smokers with airflow obstruction. Chest 130:4 (2006), 1102–1108.
7. Rose, M.C., Voynow, J.A., Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev 86:1 (2006), 245–278.
8. Itoh, Y., Kamata-Sakurai, M., Denda-Nagai, K., et al. Identification and expression of human epiglycanin/MUC21: a novel transmembrane mucin. Glycobiology 18:1 (2008), 74–83.
9. Hijikata, M., Matsushita, I., Tanaka, G., et al. Molecular cloning of two novel mucin-like genes in the disease-susceptibility locus for diffuse panbronchiolitis. Hum Genet 129:2 (2011), 117–128.
10. Culp, D.J., Robinson, B., Cash, M.N., Bhattacharyya, I., Stewart, C., Cuadra-Saenz, G., Salivary mucin 19 glycoproteins: innate immune functions in Streptococcus mutans-induced caries in mice and evidence for expression in human saliva. J Biol Chem 290:5 (2015), 2993–3008.
11. Sheehan, J.K., Kirkham, S., Howard, M., et al. Identification of molecular intermediates in the assembly pathway of the MUC5AC mucin. J Biol Chem 279:15 (2004), 15698–15705.
12. Ridley, C., Kirkham, S., Williamson, S.J., Davis, C.W., Woodman, P., Thornton, D.J., Biosynthesis of the polymeric gel-forming mucin MUC5B. Am J Physiol Lung Cell Mol Physiol 310:10 (2016), L993–L1002.
13. Yang, N., Garcia, M.A., Quinton, P.M., Normal mucus formation requires cAMP-dependent HCO3- secretion and Ca2+-mediated mucin exocytosis. J Physiol 591:18 (2013), 4581–4593.
14. Gustafsson, J.K., Ermund, A., Ambort, D., et al. Bicarbonate and functional CFTR channel are required for proper mucin secretion and link cystic fibrosis with its mucus phenotype. J Exp Med 209:7 (2012), 1263–1272.
15. Kesimer, M., Ehre, C., Burns, K.A., Davis, C.W., Sheehan, J.K., Pickles, R.J., Molecular organization of the mucins and glycocalyx underlying mucus transport over mucosal surfaces of the airways. Mucosal Immunol 6:2 (2013), 379–392.
16. Button, B., Okada, S.F., Frederick, C.B., Thelin, W.R., Boucher, R.C., Mechanosensitive ATP release maintains proper mucus hydration of airways. Sci Signal, 6(279), 2013, ra46.
17. Park, J.A., Tschumperlin, D.J., Chronic intermittent mechanical stress increases MUC5AC protein expression. Am J Respir Cell Mol Biol 41:4 (2009), 459–466.
18. Kanai, K., Koarai, A., Shishikura, Y., et al. Cigarette smoke augments MUC5AC production via the TLR3-EGFR pathway in airway epithelial cells. Respir Investig 53:4 (2015), 137–148.
19. Bautista, M.V., Chen, Y., Ivanova, V.S., Rahimi, M.K., Watson, A.M., Rose, M.C., IL-8 regulates mucin gene expression at the posttranscriptional level in lung epithelial cells. J Immunol 183:3 (2009), 2159–2166.
20. Vincent, A., Perrais, M., Desseyn, J.L., Aubert, J.P., Pigny, P., Van Seuningen, I., Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells. Oncogene 26:45 (2007), 6566–6576.
21. Gosalia, N., Leir, S.H., Harris, A., Coordinate regulation of the gel-forming mucin genes at chromosome 11p15.5. J Biol Chem 288:9 (2013), 6717–6725.
22. Ordonez, C.L., Khashayar, R., Wong, H.H., et al. Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression. Am J Respir Crit Care Med 163:2 (2001), 517–523.
23. Kim, V., Oros, M., Durra, H., et al. Chronic bronchitis and current smoking are associated with more goblet cells in moderate to severe COPD and smokers without airflow obstruction. PLoS One, 10(2), 2015, e0116108.
24. Voynow, J.A., Fischer, B.M., Roberts, B.C., Proia, A.D., Basal-like cells constitute the proliferating cell population in cystic fibrosis airways. Am J Respir Crit Care Med 172:8 (2005), 1013–1018.
25. Chen, G., Korfhagen, T.R., Karp, C.L., et al. Foxa3 induces goblet cell metaplasia and inhibits innate antiviral immunity. Am J Respir Crit Care Med 189:3 (2014), 301–313.
26. Chen, G., Korfhagen, T.R., Xu, Y., et al. SPDEF is required for mouse pulmonary goblet cell differentiation and regulates a network of genes associated with mucus production. J Clin Invest 119:10 (2009), 2914–2924.
27. Schroeder, B.W., Verhaeghe, C., Park, S.W., et al. AGR2 is induced in asthma and promotes allergen-induced mucin overproduction. Am J Respir Cell Mol Biol 47:2 (2012), 178–185.
28. Harris, J.F., Fischer, M.J., Hotchkiss, J.R., et al. Bcl-2 sustains increased mucous and epithelial cell numbers in metaplastic airway epithelium. Am J Respir Crit Care Med 171:7 (2005), 764–772.
29. Fahy, J.V., Dickey, B.F., Airway mucus function and dysfunction. N Engl J Med 363:23 (2010), 2233–2247.
30. Ha, E.V., Rogers, D.F., Novel therapies to inhibit mucus synthesis and secretion in airway hypersecretory diseases. Pharmacology 97:1-2 (2016), 84–100.
31. Dickinson, J.D., Alevy, Y., Malvin, N.P., et al. IL13 activates autophagy to regulate secretion in airway epithelial cells. Autophagy 12:2 (2016), 397–409.
32. Wlodarska, M., Thaiss, C.A., Nowarski, R., et al. NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion. Cell 156:5 (2014), 1045–1059.
33. Roy, M.G., Livraghi-Butrico, A., Fletcher, A.A., et al. Muc5b is required for airway defence. Nature 505:7483 (2014), 412–416.
34. Hasnain, S.Z., Evans, C.M., Roy, M., et al. Muc5ac: a critical component mediating the rejection of enteric nematodes. J Exp Med 208:5 (2011), 893–900.
35. Ehre, C., Worthington, E.N., Liesman, R.M., et al. Overexpressing mouse model demonstrates the protective role of Muc5ac in the lungs. Proc Natl Acad Sci U S A 109:41 (2012), 16528–16533.
36. Kim, K.C., Lillehoj, E.P., MUC1 mucin: a peacemaker in the lung. Am J Respir Cell Mol Biol 39:6 (2008), 644–647.
37. Kato, K., Uchino, R., Lillehoj, E.P., Knox, K., Lin, Y., Kim, K.C., Membrane-tethered MUC1 mucin counter-regulates the phagocytic activity of macrophages. Am J Respir Cell Mol Biol 54:4 (2016), 515–523.
38. Frenkel, E.S., Ribbeck, K., Salivary mucins in host defense and disease prevention. J Oral Microbiol, 7, 2015, 29759.
39. Johansson, M.E.V., Holmén Larsson, J.M., Hansson, G.C., The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc Natl Acad Sci U S A 108:suppl 1 (2011), 4659–4665.
40. Van der Sluis, M., De Koning, B.A., De Bruijn, A.C., et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 131:1 (2006), 117–129.
41. Velcich, A., Yang, W., Heyer, J., et al. Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 295:5560 (2002), 1726–1729.
42. McDole, J.R., Wheeler, L.W., McDonald, K.G., et al. Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine. Nature 483:7389 (2012), 345–349.
43. Knoop, K.A., McDonald, K.G., McCrate, S., McDole, J.R., Newberry, R.D., Microbial sensing by goblet cells controls immune surveillance of luminal antigens in the colon. Mucosal Immunol 8:1 (2015), 198–210.
44. Birchenough, G.M., Nystrom, E.E., Johansson, M.E., Hansson, G.C., A sentinel goblet cell guards the colonic crypt by triggering Nlrp6-dependent Muc2 secretion. Science 352:6293 (2016), 1535–1542.
45. Rajavelu, P., Chen, G., Xu, Y., Kitzmiller, J.A., Korfhagen, T.R., Whitsett, J.A., Airway epithelial SPDEF integrates goblet cell differentiation and pulmonary Th2 inflammation. J Clin Invest 125:5 (2015), 2021–2031.
46. Tanabe, T., Rubin, B.K., Airway goblet cells secrete pro-inflammatory cytokines, chemokines, and growth factors. Chest 149:3 (2016), 714–720.
47. Boucher, R.C., Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. Annu Rev Med 58 (2007), 157–170.
48. Voynow, J.A., Young, L.R., Wang, Y., Horger, T., Rose, M.C., Fischer, B.M., Neutrophil elastase increases MUC5AC mRNA and protein expression in respiratory epithelial cells. Am J Physiol 276:5 (1999), L835–L843.
49. Henke, M., Renner, A., Huber, R.M., Seeds, M.C., Rubin, B.K., MUC5AC and MUC5B mucins are decreased in cystic fibrosis airway secretions. Am J Respir Cell Mol Biol 31:1 (2004), 86–91.
50. Henderson, A.G., Ehre, C., Button, B., et al. Cystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure. J Clin Invest 124:7 (2014), 3047–3060.
51. Button, B., Anderson, W.H., Boucher, R.C., Mucus hyperconcentration as a unifying aspect of the chronic bronchitic phenotype. Ann Am Thorac Soc 13:suppl 2 (2016), S156–S162.
52. Abdullah, L.H., Evans, J.R., Wang, T.T., et al. Defective postsecretory maturation of MUC5B mucin in cystic fibrosis airways. JCI Insight, 2(6), 2017, e89752.
53. Duncan, G.A., Jung, J., Joseph, A., et al. Microstructural alterations of sputum in cystic fibrosis lung disease. JCI Insight, 1(18), 2016, e88198.
54. Shah, V.S., Ernst, S., Tang, X.X., et al. Relationships among CFTR expression, HCO3- secretion, and host defense may inform gene- and cell-based cystic fibrosis therapies. Proc Natl Acad Sci U S A 113:19 (2016), 5382–5387.
55. Garcia, M.A., Yang, N., Quinton, P.M., Normal mouse intestinal mucus release requires cystic fibrosis transmembrane regulator-dependent bicarbonate secretion. J Clin Invest 119:9 (2009), 2613–2622.
56. Gorrieri, G., Scudieri, P., Caci, E., et al. Goblet cell hyperplasia requires high bicarbonate transport to support mucin release. Sci Rep, 6, 2016, 36016.
57. Tang, X.X., Ostedgaard, L.S., Hoegger, M.J., et al. Acidic pH increases airway surface liquid viscosity in cystic fibrosis. J Clin Invest 126:3 (2016), 879–891.
58. Shah, V.S., Meyerholz, D.K., Tang, X.X., et al. Airway acidification initiates host defense abnormalities in cystic fibrosis mice. Science 351:6272 (2016), 503–507.
59. Yuan, S., Hollinger, M., Lachowicz-Scroggins, M.E., et al. Oxidation increases mucin polymer cross-links to stiffen airway mucus gels. Sci Transl Med, 7(276), 2015, 276ra227.
60. Voynow, J.A., Fischer, B.M., Zheng, S., Proteases and cystic fibrosis. Int J Biochem Cell Biol 40:6-7 (2008), 1238–1245.
61. Rubin, B.K., Priftis, K.N., Schmidt, H.J., Henke, M.O., Secretory hyperresponsiveness and pulmonary mucus hypersecretion. Chest 146:2 (2014), 496–507.
62. Cho, J.L., Ling, M.F., Adams, D.C., et al. Allergic asthma is distinguished by sensitivity of allergen-specific CD4+ T cells and airway structural cells to type 2 inflammation. Sci Transl Med, 8(359), 2016, 359ra132.
63. Evans, C.M., Raclawska, D.S., Ttofali, F., et al. The polymeric mucin Muc5ac is required for allergic airway hyperreactivity. Nat Commun, 6, 2015, 6281.
64. Alevy, Y.G., Patel, A.C., Romero, A.G., et al. IL-13-induced airway mucus production is attenuated by MAPK13 inhibition. J Clin Invest 122:12 (2012), 4555–4568.
65. Suzaki, I., Kawano, S., Komiya, K., et al. Inhibition of IL-13-induced periostin in airway epithelium attenuates cellular protein expression of MUC5AC. Respirology 22:1 (2017), 93–100.
66. Tanabe, T., Kanoh, S., Tsushima, K., Yamazaki, Y., Kubo, K., Rubin, B.K., Clarithromycin inhibits interleukin-13-induced goblet cell hyperplasia in human airway cells. Am J Respir Cell Mol Biol 45:5 (2011), 1075–1083.
67. Kanoh, S., Tanabe, T., Rubin, B.K., IL-13-induced MUC5AC production and goblet cell differentiation is steroid resistant in human airway cells. Clin Exp Allergy 41:12 (2011), 1747–1756.
68. Chen, Y., Garvin, L.M., Nickola, T.J., Watson, A.M., Colberg-Poley, A.M., Rose, M.C., IL-1β induction of MUC5AC gene expression is mediated by CREB and NF-κB and repressed by dexamethasone. Am J Physiol Lung Cell Mol Physiol 306:8 (2014), L797–L807.
69. Rubin, B.K., Tomkiewicz, R., Fahy, J.V., Green, F.H., Histopathology of fatal asthma: drowning in mucus. Pediatr Pulmonol(suppl 23), 2001, 88–89.
70. Seibold, M.A., Wise, A.L., Speer, M.C., et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med 364:16 (2011), 1503–1512.
71. Yang, I.V., Fingerlin, T.E., Evans, C.M., Schwarz, M.I., Schwartz, D.A., MUC5B and idiopathic pulmonary fibrosis. Ann Am Thorac Soc 12:suppl 2 (2015), S193–S199.
72. Evans, C.M., Fingerlin, T.E., Schwarz, M.I., et al. Idiopathic pulmonary fibrosis: a genetic disease that involves mucociliary dysfunction of the peripheral airways. Physiol Rev 96:4 (2016), 1567–1591.
73. Peljto, A.L., Zhang, Y., Fingerlin, T.E., et al. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. JAMA 309:21 (2013), 2232–2239.
74. Scholand, M.B., Wolff, R., Crossno, P.F., et al. Severity of cough in idiopathic pulmonary fibrosis is associated with MUC5 B genotype. Cough, 10, 2014, 3.
75. Hunninghake, G.M., Hatabu, H., Okajima, Y., et al. MUC5B promoter polymorphism and interstitial lung abnormalities. N Engl J Med 368:23 (2013), 2192–2200.
76. Helling, B.A., Gerber, A.N., Kadiyala, V., et al. Regulation of MUC5B expression in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 57:1 (2017), 91–99.
77. Byers, D.E., Alexander-Brett, J., Patel, A.C., et al. Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease. J Clin Invest 123:9 (2013), 3967–3982.
78. Ghosh, A., Boucher, R.C., Tarran, R., Airway hydration and COPD. Cell Mol Life Sci 72:19 (2015), 3637–3652.
79. Borchers, M.T., Carty, M.P., Leikauf, G.D., Regulation of human airway mucins by acrolein and inflammatory mediators. Am J Physiol 276:4 pt 1 (1999), L549–L555.
80. Chen, E.Y., Sun, A., Chen, C.S., Mintz, A.J., Chin, W.C., Nicotine alters mucin rheological properties. Am J Physiol Lung Cell Mol Physiol 307:2 (2014), L149–L157.
81. Fischer, B.M., Voynow, J.A., Neutrophil elastase induces MUC5AC gene expression in airway epithelium via a pathway involving reactive oxygen species. Am J Respir Cell Mol Biol 26:4 (2002), 447–452.
82. Kang, J.H., Hwang, S.M., Chung, I.Y., S100A8, S100A9 and S100A12 activate airway epithelial cells to produce MUC5AC via extracellular signal-regulated kinase and nuclear factor-κB pathways. Immunology 144:1 (2015), 79–90.
83. Shinkai, M., Rubin, B.K., Macrolides and airway inflammation in children. Paediatr Respir Rev 6:3 (2005), 227–235.
84. Bennett, W.D., Henderson, A.G., Donaldson, S.H., Hydrator therapies for chronic bronchitis: lessons from cystic fibrosis. Ann Am Thorac Soc 13:suppl 2 (2016), S186–S190.
85. Rowe, S.M., Heltshe, S.L., Gonska, T., et al. Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis. Am J Respir Crit Care Med 190:2 (2014), 175–184.
86. Shah, P.L., Scott, S.F., Knight, R.A., Marriott, C., Ranasinha, C., Hodson, M.E., In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis. Thorax 51:2 (1996), 119–125.
87. Rubin, B.K., Kater, A.P., Goldstein, A.L., Thymosin beta4 sequesters actin in cystic fibrosis sputum and decreases sputum cohesivity in vitro. Chest 130:5 (2006), 1433–1440.
88. Broughton-Head, V.J., Shur, J., Carroll, M.P., Smith, J.R., Shute, J.K., Unfractionated heparin reduces the elasticity of sputum from patients with cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 293:5 (2007), L1240–L1249.
89. Anzueto, A., Jubran, A., Ohar, J.A., et al. Effects of aerosolized surfactant in patients with stable chronic bronchitis: a prospective randomized controlled trial. JAMA 278:17 (1997), 1426–1431.
90. Albert, R.K., Connett, J., Bailey, W.C., et al. Azithromycin for prevention of exacerbations of COPD. N Engl J Med 365:8 (2011), 689–698.
91. Kobbernagel, H.E., Buchvald, F.F., Haarman, E.G., et al. Study protocol, rationale and recruitment in a European multi-centre randomized controlled trial to determine the efficacy and safety of azithromycin maintenance therapy for 6 months in primary ciliary dyskinesia. BMC Pulm Med, 16(1), 2016, 104.
92. Ribeiro, C.M., Hurd, H., Wu, Y., et al. Azithromycin treatment alters gene expression in inflammatory, lipid metabolism, and cell cycle pathways in well-differentiated human airway epithelia. PLoS One, 4(6), 2009, e5806.